Email updates

Keep up to date with the latest news and content from Virology Journal and BioMed Central.

Open Access Highly Accessed Short report

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand

Chukiat Sirivichayakul1*, Arunee Sabchareon1, Kriengsak Limkittikul1 and Sutee Yoksan2

Author Affiliations

1 Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

2 Center for Vaccine Development, Mahidol University, Nakhonpathom, Thailand

For all author emails, please log on.

Virology Journal 2014, 11:48  doi:10.1186/1743-422X-11-48

Published: 12 March 2014



The plaque reduction neutralization test (PRNT) is currently the best and most widely accepted approach to measuring virus-neutralizing and protective antibodies to dengue virus, and in assessing the immunogenicity of a dengue vaccine. However, the correlation between presence of dengue-neutralizing antibody and protection from infection is not absolute.


In a cohort study in Ratchaburi Province, Thailand, 48 subjects with serologically confirmed symptomatic dengue infection were tested for pre-existing dengue neutralizing antibody using PRNT. Nine subjects had quite high pre-existing PRNT50 titers (titer >90) to subsequent infecting dengue serotypes, but still had symptomatic infections.


This report provides evidence that PRNT may not be a good test for predicting protection against subsequent dengue infection.

Dengue; Plaque reduction neutralization test; Neutralizing antibody